Marcos Hortes N. Chagas
Marcos Hortes N. Chagas
E-mail confirmado em ufscar.br
TítuloCitado porAno
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients
MM Bergamaschi, RHC Queiroz, MHN Chagas, DCG De Oliveira, ...
Neuropsychopharmacology 36 (6), 1219, 2011
3132011
Neuroimaging in social anxiety disorder: a systematic review of the literature
MC Freitas-Ferrari, JEC Hallak, C Trzesniak, A Santos Filho, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (4), 565-580, 2010
2442010
Cannabidiol for the treatment of psychosis in Parkinson’s disease
AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ...
Journal of Psychopharmacology 23 (8), 979-983, 2009
1892009
Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions
C Meneses‐Gaya, AW Zuardi, SR Loureiro, JEC Hallak, C Trzesniak, ...
Alcoholism: Clinical and Experimental Research 34 (8), 1417-1424, 2010
1282010
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial
MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ...
Journal of Psychopharmacology 28 (11), 1088-1098, 2014
992014
Cannabidiol can improve complex sleep‐related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
MHN Chagas, AL Eckeli, AW Zuardi, MA Pena‐Pereira, ...
Journal of clinical pharmacy and therapeutics 39 (5), 564-566, 2014
722014
Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis
C Trzesniak, IR Oliveira, MJ Kempton, A Galvão-de Almeida, ...
Schizophrenia research 125 (1), 1-12, 2011
662011
Facial affect processing in social anxiety: tasks and stimuli
JP Machado-de-Sousa, KC Arrais, NT Alves, MHN Chagas, ...
Journal of neuroscience methods 193 (1), 1-6, 2010
612010
Increased amygdalar and hippocampal volumes in young adults with social anxiety
JP Machado-de-Sousa, F de Lima Osório, AP Jackowski, RA Bressan, ...
PloS one 9 (2), e88523, 2014
472014
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
SS Valvassori, G Elias, B de Souza, F Petronilho, F Dal-Pizzol, ...
Journal of Psychopharmacology 25 (2), 274-280, 2011
462011
Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease
MHN Chagas, V Tumas, SR Loureiro, JEC Hallak, C Trzesniak, ...
Parkinsonism & related disorders 16 (1), 42-45, 2010
462010
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
JAS Crippa, JEC Hallak, JP Machado‐de‐Sousa, RHC Queiroz, ...
Journal of clinical pharmacy and therapeutics 38 (2), 162-164, 2013
452013
Neuroimaging in specific phobia disorder: a systematic review of the literature
IMP Linares, C Trzesniak, MHN Chagas, JEC Hallak, AE Nardi, ...
Revista Brasileira de Psiquiatria 34 (1), 101-111, 2012
442012
Prevalence of depression in Parkinson's disease
TIK Nakabayashi, MHN Chagas, ACL Corrêa, V Tumas, SR Loureiro, ...
Archives of Clinical Psychiatry (São Paulo) 35 (6), 219-227, 2008
37*2008
Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature
JAS Crippa, GN Derenusson, MHN Chagas, Z Atakan, R Martín-Santos, ...
Harm reduction journal 9 (1), 7, 2012
362012
Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder
TS Moriyama, AC Felicio, MHN Chagas, VS Tardelli, HB Ferraz, V Tumas, ...
Journal of the neurological sciences 310 (1-2), 53-57, 2011
312011
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
MHN Chagas, JAS Crippa, AW Zuardi, JEC Hallak, ...
Journal of Psychopharmacology 27 (3), 312-316, 2013
282013
Agomelatine in the treatment of social anxiety disorder.
JA Crippa, JEC Hallak, AW Zuardi, MH Chagas, J Quevedo, AE Nardi
Progress in neuro-psychopharmacology & biological psychiatry 34 (7), 1357, 2010
282010
Oxytocin interference in the effects induced by inhalation of 7.5% CO2 in healthy volunteers
DCG de Oliveira, MHN Chagas, LV Garcia, JAS Crippa, AW Zuardi
Human Psychopharmacology: Clinical and Experimental 27 (4), 378-385, 2012
272012
Adhesio interthalamica alterations in schizophrenia spectrum disorders: a systematic review and meta-analysis
C Trzesniak, MJ Kempton, GF Busatto, IR de Oliveira, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (4), 877-886, 2011
252011
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20